| For: | Pacheco-Barcia V, Custodio-Cabello S, Carrasco-Valero F, Palka-Kotlowska M, Mariño-Mendez A, Carmona-Bayonas A, Gallego J, Martín AJM, Jimenez-Fonseca P, Cabezon-Gutierrez L. Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial. World J Gastrointest Oncol 2024; 16(2): 386-397 [PMID: 38425396 DOI: 10.4251/wjgo.v16.i2.386] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i2/386.htm |
| Number | Citing Articles |
| 1 |
Jinhao Li, Yunzhao Luo, Xinxue Zhang, Fangfei Wang, Qiang He. Impact of inflammation levels on the liver during the COVID-19 pandemic: a mediation analysis. BMC Public Health 2025; 25(1) doi: 10.1186/s12889-025-24174-1
|
| 2 |
Guofang Wang, Xuan Tang, Shijun Wang, Yu Fan. Association between weight loss and overall survival in patients with pancreatic cancer: a meta-analysis. European Journal of Cancer Prevention 2026; 35(4) doi: 10.1097/CEJ.0000000000000990
|
| 3 |
Quan Wu, Hui Zhao. Prognostic and clinicopathological role of pretreatment systemic inflammation response index (SIRI) in gastric cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology 2024; 22(1) doi: 10.1186/s12957-024-03602-3
|
| 4 |
Alberto Carmona-Bayonas, Axel Mariño Méndez, María Ángeles Vicente-Conesa, Paula Jimenez-Fonseca, María de Toro Carmena, Carmen Guillen-Ponce, Angela Lamarca, Mónica Benavente, Javier Gallego, Paula Cerdà Serdà, Raquel Hernández San Gil, Kreina Sharela Vega-Cano, Ana López, Maria Luisa Soriano Tabares de Navas, Inmaculada Peirò, Wagner Parra-Paladines, Patricia Zwisler-Contreras, Elena Brozos-Vázquez, Luis Cabezon-Gutiérrez, Andrés Muñoz Martin, Vilma Pacheco-Barcia. Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group. Pancreatology 2026; doi: 10.1016/j.pan.2026.08.008
|
| 5 |
Hailing Liao, Xiaoyan Chang, Xiaorong Hou, Fuquan Zhang. Pancreatic metastasis from cervical cancer: A case report and literature review. Oncology Letters 2025; 30(1) doi: 10.3892/ol.2025.15095
|
| 6 |
Zhe-Kun Xiong, Yu-Zi Jiang, Yan-Hua Lin, Jian-Dong Cao, Tao-Ying Deng, Yi-Yuan Zheng. Is metabolic dysfunction-associated steatotic liver disease truly irrelevant? Unmasking the heterogeneity and confounders in pancreatic cancer outcomes. World Journal of Gastroenterology 2026; 32(27): 119356 doi: 10.3748/wjg.119356
|
| 7 |
Zhenglin Zhang, Ganlin Wang, Xiaonong Dai, Wenjian Li. Association between the systemic inflammation response index and kidney stones in US adults: a cross-sectional study based on NHANES 2007–2018. Urolithiasis 2024; 52(1) doi: 10.1007/s00240-024-01668-y
|
| 8 |
Yifan Lu, Chengyin Lu, Pei Chen, Zhiqiang Luo, Wangyang Li, Hui Xiong, Yuxing Guo. Association of systemic inflammatory response index with serum uric acid levels, hyperuricemia, and gout in adults aged 20 years and older in the United States: A cross-sectional study. Medicine 2025; 104(30) doi: 10.1097/MD.0000000000043566
|
| 9 |
Júlia Vidulin, Dalibor Ondruš, Śtefan Pöršök, Melinda Kráčalíková, Vanda Ušáková, Kristián Šuták, Michaela Miškovičová, Marína Kizeková, Maroš Fremal, Jana Pisáková, Ivan Kecskés, Jaroslava Lešková, Branislav Bystrický. Survival outcomes and prognostic value of nutritional and inflammatory markers in third-line treatment of metastatic pancreatic cancer. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1713376
|
| 10 |
Huifen Shen, Fei Zuo. Prognostic role of systemic inflammation response index (SIRI) in patients with pancreatic cancer: a meta-analysis. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1465279
|